Valsalva Maneuver gets modified for the treatment of SVT
Advertisement
The first activity in the management of AV nodal—dependent supraventricular tachycardia is to try Valsalva Maneuver and there by blocking AV nodal conduction temporarily.
However, the success of the Valsalva Maneuver can be confounded by hypotension and sympathetic activation often present during supraventricular tachycardia. Thus, while the Valsalva maneuver can be a safe, fast, and easy way to stop supraventricular tachycardia, it is oftentimes ineffective.
In a controlled, prospective clinical trial performed in the emergency department, 428 participants with supraventricular tachycardia were randomized to a standard semi-recumbent Valsalva maneuver vs a semi-recumbent Valsalva maneuver with passive leg raise immediately after the maneuver.
Only 17% of the participants in the standard Valsalva maneuver group achieved a return to sinus rhythm, whereas 43% in the modified Valsalva group did, representing a highly significant difference, with an adjusted odds ratio of 3.7 in favor of the novel Valsalva approach.
This simple adjunct to the Valsalva maneuver has become a “GAME CHANGER” regarding the acute management of supraventricular tachycardias.
This approach can be used safely and more effectively in the emergency department to stop episodic supraventricular tachycardia without the need for adenosine or other interventions, but it may be useful even outside the hospital setting.
You can see a the Modified Valsalva Maneuvre on the following video
[embed]https://www.youtube.com/watch?v=8DIRiOA_OsA[/embed]
You can read the full article about this modified Valsalva Maneuver at Lancet by clicking on the following link
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2961485-4/fulltext
However, the success of the Valsalva Maneuver can be confounded by hypotension and sympathetic activation often present during supraventricular tachycardia. Thus, while the Valsalva maneuver can be a safe, fast, and easy way to stop supraventricular tachycardia, it is oftentimes ineffective.
In a controlled, prospective clinical trial performed in the emergency department, 428 participants with supraventricular tachycardia were randomized to a standard semi-recumbent Valsalva maneuver vs a semi-recumbent Valsalva maneuver with passive leg raise immediately after the maneuver.
Only 17% of the participants in the standard Valsalva maneuver group achieved a return to sinus rhythm, whereas 43% in the modified Valsalva group did, representing a highly significant difference, with an adjusted odds ratio of 3.7 in favor of the novel Valsalva approach.
This simple adjunct to the Valsalva maneuver has become a “GAME CHANGER” regarding the acute management of supraventricular tachycardias.
This approach can be used safely and more effectively in the emergency department to stop episodic supraventricular tachycardia without the need for adenosine or other interventions, but it may be useful even outside the hospital setting.
You can see a the Modified Valsalva Maneuvre on the following video
[embed]https://www.youtube.com/watch?v=8DIRiOA_OsA[/embed]
You can read the full article about this modified Valsalva Maneuver at Lancet by clicking on the following link
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2815%2961485-4/fulltext
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.